SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-079719
Filing Date
2021-03-12
Accepted
2021-03-12 16:33:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d150017d424b5.htm 424B5 437054
2 GRAPHIC g150017g46w53.jpg GRAPHIC 47816
3 GRAPHIC g150017g74n27.jpg GRAPHIC 46421
  Complete submission text file 0001193125-21-079719.txt   563579
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233061 | Film No.: 21737920
SIC: 2834 Pharmaceutical Preparations